ArticleMolecular and cellular biochemistry2024

A novel 2-iminobenzimidazole compound, XYA1353, displays in vitro and in vivo anti-myeloma activity via targeting NF-κB signaling.

Jian Gao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.